Edward Saltzman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Edward Saltzman has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Sarah L. Booth
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
2 shared publications - Susan B. Roberts
Geisel School of Medicine, Dartmouth College, Hanover, USA
2 shared publications - Amanda Ruth Vest
Kaufman Center for Heart Failure Treatment and Recovery, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA
1 shared publication Amy Krauss
USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
1 shared publication- Anastassios G. Pittas
Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA
1 shared publication - Anindita Chanda
Department of Internal Medicine University of Connecticut School of Medicine Farmington Connecticut USA
1 shared publication
Latest Publications
- Open Access
- 4 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (13) , e029086
Cardiac Cachexia in Left Ventricular Assist Device Recipients and the Implications of Weight Gain Early After Implantation
Background: Severe cardiac cachexia or malnutrition are commonly considered relative contraindications to left ventricular assist device (LVAD) implantation, but post‐LVAD prognosis for patients with cachexia is uncertain. Methods and Results: Intermacs (Interagency Registry for Mechanically Assisted Circulatory Support) 2006 to 2017 was queried for the preimplantation variable cachexia/malnutrition. Cox proportional hazards modeling examined the relationship between cachexia and LVAD outcomes. Of 20 332 primary LVAD recipients with available data, 516 (2.54%) were reported to have baseline cachexia and had higher risk baseline characteristics. Cachexia was associated with higher mortality during LVAD support (unadjusted hazard ratio [HR], 1.36 [95% CI, 1.18–1.56]; P P =0.005). Mean weight change at 12 months was +3.9±9.4 kg. Across the cohort, weight gain ≥5% during the first 3 months of LVAD support was associated with lower mortality (unadjusted HR, 0.90 [95% CI, 0.84–0.98]; P =0.012; adjusted HR, 0.89 [95% CI, 0.82–0.97]; P =0.006). Conclusions: The proportion of LVAD recipients recognized to have cachexia preimplantation was low at 2.5%. Recognized cachexia was independently associated with higher mortality during LVAD support. Early weight gain ≥5% was independently associated with lower mortality during subsequent LVAD support.
- 4 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (13) , e029086
Open AccessCardiac Cachexia in Left Ventricular Assist Device Recipients and the Implications of Weight Gain Early After Implantation
Background: Severe cardiac cachexia or malnutrition are commonly considered relative contraindications to left ventricular assist device (LVAD) implantation, but post‐LVAD prognosis for patients with cachexia is uncertain. Methods and Results: Intermacs (Interagency Registry for Mechanically Assisted Circulatory Support) 2006 to 2017 was queried for the preimplantation variable cachexia/malnutrition. Cox proportional hazards modeling examined the relationship between cachexia and LVAD outcomes. Of 20 332 primary LVAD recipients with available data, 516 (2.54%) were reported to have baseline cachexia and had higher risk baseline characteristics. Cachexia was associated with higher mortality during LVAD support (unadjusted hazard ratio [HR], 1.36 [95% CI, 1.18–1.56]; P P =0.005). Mean weight change at 12 months was +3.9±9.4 kg. Across the cohort, weight gain ≥5% during the first 3 months of LVAD support was associated with lower mortality (unadjusted HR, 0.90 [95% CI, 0.84–0.98]; P =0.012; adjusted HR, 0.89 [95% CI, 0.82–0.97]; P =0.006). Conclusions: The proportion of LVAD recipients recognized to have cachexia preimplantation was low at 2.5%. Recognized cachexia was independently associated with higher mortality during LVAD support. Early weight gain ≥5% was independently associated with lower mortality during subsequent LVAD support.
- Open Access
- 1 November 2017
- Published by Elsevier in Current Developments in Nutrition
- Vol. 1 (11) , e000885
A Pilot Randomized Controlled Trial of a New Supplementary Food Designed to Enhance Cognitive Performance during Prevention and Treatment of Malnutrition in Childhood
Background: Cognitive impairment associated with childhood malnutrition and stunting is generally considered irreversible.Objective: The aim was to t
- 1 November 2017
- Published by Elsevier in Current Developments in Nutrition
- Vol. 1 (11) , e000885
Open AccessA Pilot Randomized Controlled Trial of a New Supplementary Food Designed to Enhance Cognitive Performance during Prevention and Treatment of Malnutrition in Childhood
Background: Cognitive impairment associated with childhood malnutrition and stunting is generally considered irreversible.Objective: The aim was to t
- Open Access
- 26 September 2008
- Published by Bentham Science Publishers Ltd. in The Open Nutrition Journal
- Vol. 2 (1) , 76-85
Long - Term Effects of Energy-Restricted Diets Differing in Glycemic Load on Metabolic Adaptation and Body Composition*
A randomized controlled trial of high glycemic load (HG) and low glycemic load (LG) diets with food provided for 6 months and self-administered for 6 additional months at 30% caloric restriction (CR) was performed in 29 overweight adults (mean+/-SD, age 35+/-5y; BMI 27.5+/-1.5 kg/m(2)). Total energy expenditure (TEE), resting metabolic rate (RMR), fat and fat free mass (FFM), were measured at 3, 6 and 12 months. Changes in TEE, but not changes in RMR, were greater than accounted for by the loss of FFM and fat mass (P=0.001-0.013) suggesting an adaptive response to long-term CR. There was no significant effect of diet group on change in RMR or TEE. However, in subjects who lost >5% body weight (n=26), the LG diet group had a higher percentage of weight loss as fat than the HG group (p<0.05), a finding that may have implications for dietary recommendations during weight reduction.
- 26 September 2008
- Published by Bentham Science Publishers Ltd. in The Open Nutrition Journal
- Vol. 2 (1) , 76-85
Open AccessLong - Term Effects of Energy-Restricted Diets Differing in Glycemic Load on Metabolic Adaptation and Body Composition*
A randomized controlled trial of high glycemic load (HG) and low glycemic load (LG) diets with food provided for 6 months and self-administered for 6 additional months at 30% caloric restriction (CR) was performed in 29 overweight adults (mean+/-SD, age 35+/-5y; BMI 27.5+/-1.5 kg/m(2)). Total energy expenditure (TEE), resting metabolic rate (RMR), fat and fat free mass (FFM), were measured at 3, 6 and 12 months. Changes in TEE, but not changes in RMR, were greater than accounted for by the loss of FFM and fat mass (P=0.001-0.013) suggesting an adaptive response to long-term CR. There was no significant effect of diet group on change in RMR or TEE. However, in subjects who lost >5% body weight (n=26), the LG diet group had a higher percentage of weight loss as fat than the HG group (p<0.05), a finding that may have implications for dietary recommendations during weight reduction.
- Open Access
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 1106.4
Phylloquinone intake is associated with glucose metabolism in middle‐ and older‐aged men and women
Animal and metabolic studies suggest that vitamin K may have a beneficial role in glucose homeostasis. The aim of this study was to examine the association between vitamin K intake and measures of glucose metabolism in a community‐based sample of healthy adults. We assessed the cross‐sectional associations between phylloquinone (vitamin K 1 ) intake and glucose metabolism measures in the 2778 participants (1277 men and 1501 women; mean age, 54 y) of the Framingham Offspring Cohort Study. Phylloquinone intakes were assessed by food frequency questionnaire. Surrogate measures of glucose metabolism included fasting and 2‐h post oral glucose tolerance test (OGTT) glucose and insulin, and HbA 1c . Associations of glucose metabolism measures with phylloquinone intakes were assessed using the analysis of covariance with Bonferroni adjustment for the multiple outcomes. Lower phylloquinone intake was associated with higher 2‐h glucose and insulin concentrations after adjustment for age, sex, waist circumference, lifestyle characteristics and diet quality (2‐h glucose: 106.4 mg/dL vs. 102.1 mg/dL in the lowest compared to the highest quintile, P ‐trend = 0.05; 2‐h insulin: 80.2 μU/mL vs. 72.0 μU/mL, P ‐trend = 0.02), but was not associated with fasting glucose and insulin concentrations and HbA 1c . Our findings suggest a potential beneficial association of phylloquinone intake with glucose metabolism in the fed state.
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 1106.4
Open AccessPhylloquinone intake is associated with glucose metabolism in middle‐ and older‐aged men and women
Animal and metabolic studies suggest that vitamin K may have a beneficial role in glucose homeostasis. The aim of this study was to examine the association between vitamin K intake and measures of glucose metabolism in a community‐based sample of healthy adults. We assessed the cross‐sectional associations between phylloquinone (vitamin K 1 ) intake and glucose metabolism measures in the 2778 participants (1277 men and 1501 women; mean age, 54 y) of the Framingham Offspring Cohort Study. Phylloquinone intakes were assessed by food frequency questionnaire. Surrogate measures of glucose metabolism included fasting and 2‐h post oral glucose tolerance test (OGTT) glucose and insulin, and HbA 1c . Associations of glucose metabolism measures with phylloquinone intakes were assessed using the analysis of covariance with Bonferroni adjustment for the multiple outcomes. Lower phylloquinone intake was associated with higher 2‐h glucose and insulin concentrations after adjustment for age, sex, waist circumference, lifestyle characteristics and diet quality (2‐h glucose: 106.4 mg/dL vs. 102.1 mg/dL in the lowest compared to the highest quintile, P ‐trend = 0.05; 2‐h insulin: 80.2 μU/mL vs. 72.0 μU/mL, P ‐trend = 0.02), but was not associated with fasting glucose and insulin concentrations and HbA 1c . Our findings suggest a potential beneficial association of phylloquinone intake with glucose metabolism in the fed state.
- 18 March 2006
- Published by Springer Nature in Osteoporosis International
- Vol. 17 (6) , 929-935
Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism
Introduction Vitamin K has been implicated in increased bone fracture risk. Despite a potential role of vitamin K in bone, little is known about the effects of altered dietary phylloquinone intake on the underlying components of bone and mineral metabolism. Methods A 84-day in-house dietary phylloquinone (vitamin K) depletion–repletion study was undertaken in 21 postmenopausal women (mean age: 70 years) to assess the effects of altered vitamin K status on intestinal calcium (Ca) absorption, urinary and serum Ca and phosphorus (P), serum calcemic hormones, and serum biomarkers of bone turnover [osteocalcin and N-telopeptide type 1 collagen cross-links (NTx)] and the response to 1,25-dihydroxyvitamin D treatment (1 μg/day×7 d). Results The group receiving calcitriol treatment (n=11) had higher Ca absorption, urinary Ca, urinary and serum P and serum osteocalcin and lower serum parathyroid hormone (PTH).There were no significant effects of acute (4-week) phylloquinone depletion on response to 1,25-dihydroxyvitamin D treatment or on measures of bone formation or mineral metabolism. However, phylloquinone treatment had a significant effect (p p< 0.01). Conclusions These findings suggest that altering vitamin K status in postmenopausal women by manipulating phylloquinone intake does not have an acute affect on intestinal Ca absorption, renal mineral excretion, or bone formation, but high phylloquinone intake may modestly reduce bone resorption. The impact of high phylloquinone intake on bone mineral density and fracture risk needs to be ascertained in randomized clinical trials.
- 18 March 2006
- Published by Springer Nature in Osteoporosis International
- Vol. 17 (6) , 929-935
Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism
Introduction Vitamin K has been implicated in increased bone fracture risk. Despite a potential role of vitamin K in bone, little is known about the effects of altered dietary phylloquinone intake on the underlying components of bone and mineral metabolism. Methods A 84-day in-house dietary phylloquinone (vitamin K) depletion–repletion study was undertaken in 21 postmenopausal women (mean age: 70 years) to assess the effects of altered vitamin K status on intestinal calcium (Ca) absorption, urinary and serum Ca and phosphorus (P), serum calcemic hormones, and serum biomarkers of bone turnover [osteocalcin and N-telopeptide type 1 collagen cross-links (NTx)] and the response to 1,25-dihydroxyvitamin D treatment (1 μg/day×7 d). Results The group receiving calcitriol treatment (n=11) had higher Ca absorption, urinary Ca, urinary and serum P and serum osteocalcin and lower serum parathyroid hormone (PTH).There were no significant effects of acute (4-week) phylloquinone depletion on response to 1,25-dihydroxyvitamin D treatment or on measures of bone formation or mineral metabolism. However, phylloquinone treatment had a significant effect (p p< 0.01). Conclusions These findings suggest that altering vitamin K status in postmenopausal women by manipulating phylloquinone intake does not have an acute affect on intestinal Ca absorption, renal mineral excretion, or bone formation, but high phylloquinone intake may modestly reduce bone resorption. The impact of high phylloquinone intake on bone mineral density and fracture risk needs to be ascertained in randomized clinical trials.
- 1 January 1997
- Published by Springer Nature
- Vol. 427, 89-97
Soluble Fiber and Energy Regulation
Americans are becoming fatter. Recent longitudinal data from the National Health and Nutrition Examination Survey1 shows that the median body mass index of adult men and women increased from 25.3 to 26.3 kg/m2 between the periods 1960–1962 and 1988–1991, corresponding to a body weight gain of 8 lb. While it is clear that the immediate underlying cause of this increase can be traced to an energy intake greater than energy expenditure, the underlying causes of the imbalance remain unclear. Has metabolizable energy intake increased, or has energy expenditure fallen, or has a combination of these two events occurred? If metabolizable energy intake has increased, why has this happened? In this brief review we focus on the potential role of soluble fiber in influencing energy intake and hence body weight regulation, and on some experimental considerations for future investigational studies in this area.
- 1 January 1997
- Published by Springer Nature
- Vol. 427, 89-97
Soluble Fiber and Energy Regulation
Americans are becoming fatter. Recent longitudinal data from the National Health and Nutrition Examination Survey1 shows that the median body mass index of adult men and women increased from 25.3 to 26.3 kg/m2 between the periods 1960–1962 and 1988–1991, corresponding to a body weight gain of 8 lb. While it is clear that the immediate underlying cause of this increase can be traced to an energy intake greater than energy expenditure, the underlying causes of the imbalance remain unclear. Has metabolizable energy intake increased, or has energy expenditure fallen, or has a combination of these two events occurred? If metabolizable energy intake has increased, why has this happened? In this brief review we focus on the potential role of soluble fiber in influencing energy intake and hence body weight regulation, and on some experimental considerations for future investigational studies in this area.